SynthesisThe Cochrane database of systematic reviews2022

Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer.

Abigail Tattersall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.